Stroke Risk After Mitral Valve Interventions: A Systematic Review and Network Meta-Analysis.

Previous research indicates varying stroke rates after mitral valve (MV) interventions. This study aimed to compare post-procedural stroke risks following transcatheter and surgical MV interventions. Electronic databases were searched from inception to February 2024 for studies comparing stroke rates after mitral transcatheter edge-to-edge repair (mTEER), surgical MV repair/replacement, or guideline-directed medical therapy (GDMT). Primary endpoints were all-time and early (<30 days) stroke. Secondary outcomes included new-onset atrial fibrillation and 1-year all-cause mortality. A frequentist network meta-analysis was employed to compare outcomes. The network meta-analysis included 18 studies (3 randomized clinical trials and 15 observational), with 51,703 patients. mTEER was associated with a decreased risk of all-time (odds ratio [OR] 0.61, 95% CI 0.41-0.89) and early stroke (OR 0.41, 95% CI 0.33-0.51) compared with surgery, and a similar risk of all-time (OR 1.54, 95% CI 0.76-3.12) and early stroke (OR 2.12, 95% CI 0.53-8.47) compared with GDMT. Conversely, surgery was associated with an increased risk of all-time (OR 2.55, 95% CI 1.17-5.57) and early stroke (OR 5.15, 95% CI 1.27-20.84) compared with GDMT. There were no statistically significant differences in the risk of new-onset atrial fibrillation (OR 0.38, 95% CI 0.11-1.31) and 1-year all-cause mortality (OR 1.43, 95% CI 0.91-2.24) between mTEER vs. surgery. In conclusion, mTEER was associated with a lower risk of stroke and similar risks of new-onset atrial fibrillation and 1-year mortality compared with surgical MV interventions. Further studies are needed to understand the mechanisms of stroke and to determine strategies to reduce stroke risk following MV interventions.

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.